Last $49.50 USD
Change Today -0.41 / -0.82%
Volume 519.4K
As of 8:10 PM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

neogen corp (NEOG) Snapshot

Open
$49.61
Previous Close
$49.91
Day High
$49.94
Day Low
$48.76
52 Week High
02/27/15 - $51.97
52 Week Low
05/15/14 - $35.50
Market Cap
1.8B
Average Volume 10 Days
164.8K
EPS TTM
$0.83
Shares Outstanding
37.0M
EX-Date
--
P/E TM
59.4x
Dividend
--
Dividend Yield
--
Current Stock Chart for NEOGEN CORP (NEOG)

Related News

No related news articles were found.

neogen corp (NEOG) Related Businessweek News

No Related Businessweek News Found

neogen corp (NEOG) Details

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products and services for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug and pesticide residues, and general sanitation concerns; and AccuPoint rapid sanitation test for adenosine triphosphate, a chemical found in living cells. It offers its products primarily to food and feed processors, meat and poultry processors, seafood processors, fruit and vegetable producers, grain producers and processors, and dairies; laboratories; producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products; and various regulatory agencies. The Animal Safety segment provides pharmaceuticals, rodenticides, disinfectants, vaccines, veterinary instruments, topicals, diagnostic products, and genetic testing services to the animal safety market. This segment’s drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm animals and racing animals, such as horses, greyhounds, and camels; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. Its products are also used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. In addition, this segment offers various products for researchers to detect biologically-active substances; and proprietary substrates for other diagnostic test kit manufacturers. The company sells its products directly, as well as through distributors and retail chains. Neogen Corporation was founded in 1981 and is headquartered in Lansing, Michigan.

926 Employees
Last Reported Date: 07/30/14
Founded in 1981

neogen corp (NEOG) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $532.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $233.0K
Vice President of Animal Safety Operations
Total Annual Compensation: $213.0K
Vice President of Food Safety Operations
Total Annual Compensation: $194.0K
Compensation as of Fiscal Year 2014.

neogen corp (NEOG) Key Developments

Neogen Launches Bottle Mount Vaccinator

Neogen has launched Prima Marc bottle mount vaccinator, or BMV. The company has expanded its line of highly accurate Prima Marc products a veterinary syringe that simultaneously injects and marks an animal - and at the same time provides an animal care provider the mobility of a bottle mount vaccinator (BMV). Neogen's unique new Prima Marc BMV allows users to inject and mark the animal with a single motion using only one hand. The bottle of medication or vaccine is directly connected to the syringe, and a can of Prima Marc paint is mounted to the top of the device. A squeeze of the syringe's handle activates the mounted paint can, and marks each animal as it is serviced.

Neogen Corp. Presents at Cowen and Company 35th Annual Healthcare Conference, Mar-03-2015 10:40 AM

Neogen Corp. Presents at Cowen and Company 35th Annual Healthcare Conference, Mar-03-2015 10:40 AM. Venue: The Boston Marriott Copley Place, Boston, Massachusetts, United States.

Neogen Corp. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended November 30, 2014

Neogen Corp. reported unaudited consolidated earnings results for the second quarter and six months ended November 30, 2014. For the quarter, the company reported total revenue of $68,455,000 compared to $59,599,000 a year ago. Operating income was $12,897,000 compared to $9,689,000 a year ago. Income before tax was $12,426,000 compared to $9,728,000 a year ago. Net income was $7,826,000 compared to $6,228,000 a year ago. Net income attributable to the company shareholders was $7,806,000 compared to $6,207,000 a year ago. Diluted net income per share was $0.21 compared to $0.17 a year ago. For the six months, the company reported total revenue of $136,054,000 compared to $118,147,000 a year ago. Operating income was $26,336,000 compared to $22,107,000 a year ago. Income before tax was $26,135,000 compared to $21,624,000 a year ago. Net income was $16,735,000 compared to $13,924,000 a year ago. Net income attributable to the company shareholders was $16,689,000 compared to $14,045,000 a year ago. Diluted net income per share was $0.45 compared to $0.38 a year ago. The company generated cash nicely with cash provided by operations of $23 million during the year-to-date.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NEOG:US $49.50 USD -0.41

NEOG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Biomerica Inc $0.90 USD 0.00
BioMerieux €95.19 EUR -0.43
IDEXX Laboratories Inc $157.23 USD -2.23
OraSure Technologies Inc $7.18 USD -0.13
Roka Bioscience Inc $4.43 USD +0.22
View Industry Companies
 

Industry Analysis

NEOG

Industry Average

Valuation NEOG Industry Range
Price/Earnings 60.5x
Price/Sales 6.9x
Price/Book 5.6x
Price/Cash Flow 59.9x
TEV/Sales 6.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEOGEN CORP, please visit www.neogen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.